Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine plus dexmedetomidine dosing for percutaneous transforaminal endoscopic discectomy
ChiCTR2300068206Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Gannan Medical University
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine and dexmedetomidine in Herniated Lumbar Disk (3 arms), sponsored by First Affiliated Hospital of Gannan Medical University. Primary endpoint: visual analogue scale. Planned start Jan 2023; status: not yet recruiting.
02
Drugs
esketaminedexmedetomidine
03
Conditions
Herniated Lumbar Disk
Beyond the preview
Go deeper on ChiCTR2300068206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300068206.